Show simple item record

dc.contributor.authorAfantitis, Antreasen
dc.contributor.authorMelagraki, G.en
dc.contributor.authorSarimveis, H.en
dc.contributor.authorKoutentis, Panayiotis Andreasen
dc.contributor.authorIgglessi-Markopoulou, O.en
dc.contributor.authorKollias, G.en
dc.creatorAfantitis, Antreasen
dc.creatorMelagraki, G.en
dc.creatorSarimveis, H.en
dc.creatorKoutentis, Panayiotis Andreasen
dc.creatorIgglessi-Markopoulou, O.en
dc.creatorKollias, G.en
dc.date.accessioned2019-11-21T06:16:14Z
dc.date.available2019-11-21T06:16:14Z
dc.date.issued2010
dc.identifier.issn1381-1991
dc.identifier.urihttp://gnosis.library.ucy.ac.cy/handle/7/55229
dc.description.abstractAnovelQSARworkflowis constructed that combines MLR with LS-SVM classification techniques for the identification of quinazolinone analogs as "active" or "nonactive" CXCR3 antagonists. The accuracy of the LS-SVM classification technique for the training set and testwas 100% and 90%, respectively. For the "active" analogs a validated MLR QSAR model estimates accurately their I-IP10 IC50 inhibition values. The accuracy of the QSAR model (R2 =0.80) is illustrated using various evaluation techniques, such as leave-one-out procedure (R2 LOO = 0.67) and validation through an external test set (R 2 pred = 0.78). The key conclusion of this study is that the selected molecular descriptors, Highest Occupied Molecular Orbital energy (HOMO), Principal Moment of Inertia along X and Y axes PMIX and PMIZ, Polar Surface Area (PSA), Presence of triple bond (PTrplBnd), and Kier shape descriptor (1κ), demonstrate discriminatory and pharmacophore abilities.en
dc.sourceMolecular diversityen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-77954670462&doi=10.1007%2fs11030-009-9163-7&partnerID=40&md5=55d99fa91f1c870b0d09d33654164d15
dc.subjectregression analysisen
dc.subjectarticleen
dc.subjectAlgorithmsen
dc.subjectalgorithmen
dc.subjectpredictionen
dc.subjectpriority journalen
dc.subjectLeast-Squares Analysisen
dc.subjectstatistical modelen
dc.subjectReproducibility of Resultsen
dc.subjectantiinflammatory agenten
dc.subjectsensitivity and specificityen
dc.subjectchemistryen
dc.subjectLinear Modelsen
dc.subjectreproducibilityen
dc.subjectvalidation studyen
dc.subjectdrug antagonismen
dc.subjectcomputer modelen
dc.subjectmolecular modelen
dc.subjectIC 50en
dc.subjectInhibitory Concentration 50en
dc.subjectQSARen
dc.subjectquantitative structure activity relationen
dc.subjectQuantitative Structure-Activity Relationshipen
dc.subjectpharmacophoreen
dc.subjectchemical modelen
dc.subjectchemokine receptor CXCR3en
dc.subjectCXCR3en
dc.subjectIn silico predictionsen
dc.subjectkernel methoden
dc.subjectleast squares support vector machineen
dc.subjectModels, Chemicalen
dc.subjectMolecular modellingen
dc.subjectquinazolinone derivativeen
dc.subjectQuinazolinonesen
dc.subjectradial based functionen
dc.subjectreceptor blockingen
dc.subjectReceptors, CXCR3en
dc.subjectsupport vector machineen
dc.titleA combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogsen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s11030-009-9163-7
dc.description.volume14
dc.description.issue2
dc.description.startingpage225
dc.description.endingpage235
dc.author.faculty002 Σχολή Θετικών και Εφαρμοσμένων Επιστημών / Faculty of Pure and Applied Sciences
dc.author.departmentΤμήμα Χημείας / Department of Chemistry
dc.type.uhtypeArticleen
dc.description.notes<p>Cited By :38</p>en
dc.source.abbreviationMol.Diversityen
dc.contributor.orcidKoutentis, Panayiotis Andreas [0000-0002-4652-7567]
dc.contributor.orcidAfantitis, Antreas [0000-0002-0977-8180]
dc.contributor.orcidIgglessi-Markopoulou, O. [0000-0002-7683-8526]
dc.gnosis.orcid0000-0002-4652-7567
dc.gnosis.orcid0000-0002-0977-8180|0000-0002-7683-8526


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record